These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34335761)

  • 1. Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
    Tu Z; Tian T; Chen Q; Li C
    J Oncol; 2021; 2021():8052752. PubMed ID: 34335761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nomogram for Identifying Candidates for Adjuvant Chemotherapy in Patients With Stage IB Non-small Cell Lung Cancer.
    Song X; Xie Y; Deng H; Yu F; Wang S; Lou Y
    Cancer Control; 2023; 30():10732748231177541. PubMed ID: 37204026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
    Tu Z; Li C; Tian T; Chen Q
    Lung Cancer; 2021 Nov; 161():114-121. PubMed ID: 34583219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.
    Zhai W; Gong L; Zheng Y; Yan Q; Lai R; Liang D; Wong W; Dai S; Wang J
    Front Oncol; 2022; 12():851276. PubMed ID: 35402251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
    Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
    J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer.
    Wang W; Teng F; Bu S; Xu W; Cai QC; Jiang YQ; Wang ZQ
    Risk Manag Healthc Policy; 2022; 15():1581-1592. PubMed ID: 36046766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
    Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
    Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of adjuvant chemotherapy in elderly patients with stage IB-IIIB non-small cell lung cancer: a propensity-matched analysis.
    Qin X; Xiao X; Xia H; Yang K; Zhang S
    Transl Cancer Res; 2024 Jun; 13(6):3003-3015. PubMed ID: 38988934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
    Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
    Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
    Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer.
    Yang H; Li X; Shi J; Fu H; Yang H; Liang Z; Xiong H; Wang H
    Cancer Manag Res; 2018; 10():6611-6626. PubMed ID: 30584357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study.
    Luan K; Addeo A; Flores RM; Seki N; Liu A
    J Thorac Dis; 2024 Mar; 16(3):2125-2141. PubMed ID: 38617791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical nomogram and heat map for assessing survival in patients with stage I non-small cell lung cancer after complete resection.
    Cao X; Zheng YZ; Liao HY; Guo X; Li Y; Wang Z; Zhang L; Wang XD; Wang X
    Ther Adv Med Oncol; 2020; 12():1758835920970063. PubMed ID: 33224277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.